KM Research Hub
← 返回论文库
待处理 入排:待复核 图源:待检查 入排置信度 0.60

The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma.

Hanneke W M van Laarhoven, Sarah Derks

Cell Rep Med 4(4) 100990

PMID37075702
PMCIDPMC10140387
DOI10.1016/j.xcrm.2023.100990
发表日期2023-04-19
入排依据:The record describes a Phase III RCT with drug intervention in oncology, but the abstract does not explicitly specify a time-to-event efficacy endpoint (like OS, PFS, DFS, etc.) or Kaplan-Meier/HR data. Without this information, the time_to_event criterion cannot be established.
摘要

摘要

In the ASTRUM-007 randomized double-blind phase III study, Song et al.1 showed that the combination of PD-1 inhibitors with first-line fluoropyrimidine and platinum-based chemotherapy improves outcomes in PD-L1-overexpressing esophageal squamous cell carcinomas.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。